NAI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NAI, covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma [Phase 2]